CVE-2008-1716

Description

Cross-site scripting (XSS) vulnerability in WoltLab Community Framework (WCF) 1.0.6 in WoltLab Burning Board 3.0.5 allows remote attackers to inject arbitrary web script or HTML via the (1) page and (2) form parameters, which are not properly handled when they are reflected back in an error message.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.47%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://secunia.com/advisories/29719 third party advisory vendor advisory
http://www.securityfocus.com/archive/1/490782/100/0/threaded mailing list
http://www.securityfocus.com/bid/28678 vdb entry
http://archives.neohapsis.com/archives/fulldisclosure/2008-04/0161.html mailing list
https://exchange.xforce.ibmcloud.com/vulnerabilities/41714 vdb entry
http://www.securityfocus.com/archive/1/490560/100/0/threaded mailing list
http://lists.grok.org.uk/pipermail/full-disclosure/2008-April/061271.html mailing list

Frequently Asked Questions

What is the severity of CVE-2008-1716?
CVE-2008-1716 has been scored as a medium severity vulnerability.
How to fix CVE-2008-1716?
To fix CVE-2008-1716, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-1716 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2008-1716 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.